Products

AI-ECG Platform
Shenzhen Carewell Electronics Co., Ltd.
Cardiology AI
The AI-ECG Platform by Shenzhen Carewell Electronics is an FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy.
AI-ECG Tracker
Shenzhen Carewell Electronics Co.
Cardiology AI
Shenzhen Carewell Electronics Co., a subsidiary of Lepu Medical, is a pioneer in applying artificial intelligence technology to ECG auto-diagnosis, distributing innovative AI medical devices to over 100 countries.

See all 2 products →

About Shenzhen Carewell Electronics

Shenzhen Carewell Electronics Co., Ltd. (Carewell), a subsidiary of Lepu Medical, is a high-tech enterprise specializing in the research, development, manufacturing, marketing, and after-sale service of advanced medical equipment. The company is recognized as a pioneer in applying artificial intelligence (AI) technology to ECG auto-diagnosis, aiming to enhance the accuracy and efficiency of cardiac diagnoses and expand access to ECG diagnosis in primary medical facilities.

Carewell’s product portfolio includes a wide range of medical devices such as electrocardiographs (ECG machines), multi-parameter patient monitors, ultrasound scanners, infusion and syringe pumps, medical imaging systems, obstetric products, electro-surgical generators, and veterinary products. Their AI-ECG Platform, an AI automatic analysis and diagnosis system for ECG, received clearance from the U.S. Food and Drug Administration (FDA) in November 2018. This AI-ECG Tracker is designed to assist qualified healthcare professionals in hospitals and healthcare facilities with the assessment of arrhythmias using ECG data, by providing automated analysis and interpretation that physicians can review and modify. The company’s analytics system has integrated a vast dataset, including 47 million pieces of data collected from over half a million patients across 2,500 Chinese hospitals. Carewell’s products are distributed to hospitals, clinics, health centers, and medical research institutions in more than 100 countries globally.

Focus Areas

AI ECG auto-diagnosis cardiovascular disease diagnosis arrhythmia detection myocardial infarction detection ventricular hypertrophy detection medical imaging systems multi-parameter patient monitoring deep learning algorithms medical device software

Business Intelligence

Key InvestorsLepu Medical (Parent Company), Intel (Strategic Partner)
PartnershipsIntel (strategic cooperation agreement for AI application in healthcare, 2019)
AcquisitionsJoined Lepu Medical in 2017
TechnologyAI-powered analysis system, deep learning algorithms, neural networks, powerful GPU for AI computing, Intel's AI chips, OpenVINO framework, hardware-independent platform, web-based management portal, Windows-based diagnostic client
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

AI-Powered ECG Auto-Diagnosis
Specializes in rapid and accurate AI-driven interpretation of ECGs, including sophisticated detection of arrhythmias, myocardial infarction, and ventricular hypertrophy. This capability significantly enhances early diagnosis and supports timely clinical intervention.
Comprehensive Cardiovascular Diagnostics
Offers advanced solutions for broad cardiovascular disease diagnosis, leveraging deep learning algorithms to provide deeper insights and support clinical decision-making across a spectrum of cardiac conditions.
Integrated Patient Monitoring & Imaging Systems
Develops multi-parameter patient monitoring systems and medical imaging solutions, potentially integrating AI for enhanced data analysis and diagnostic support across various modalities, offering a holistic view of patient health.
Core Deep Learning & Medical Software Expertise
Built on a foundation of proprietary deep learning algorithms and robust medical device software development, ensuring high reliability, accuracy, and regulatory compliance in their products, which is critical for clinical applications.
Physician Tip

For physicians, Shenzhen Carewell Electronics stands out by offering solutions that promise enhanced diagnostic precision and speed, particularly in complex ECG interpretations. Their AI-driven auto-diagnosis can significantly streamline workflow, reduce interpretation time, and aid in the early and accurate detection of critical cardiovascular conditions like MI and arrhythmias, potentially leading to better patient outcomes. The focus on reliable medical device software also ensures trustworthy and compliant tools for clinical practice. Consider how their integrated monitoring and imaging systems could provide a more comprehensive patient overview and decision support.

While not explicitly detailed, companies specializing in medical device software and AI diagnostics typically design their systems with potential integration into existing hospital information systems (HIS), Electronic Health Records (EHR), and Picture Archiving and Communication Systems (PACS) to facilitate seamless data flow and workflow efficiency within clinical environments.

Products by Shenzhen Carewell Electronics

2 products in the directory

AI-ECG Platform
Shenzhen Carewell Electronics Co., Ltd.
Cardiology AI
The AI-ECG Platform by Shenzhen Carewell Electronics is an FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy.
AI-ECG Tracker
Shenzhen Carewell Electronics Co.
Cardiology AI
Shenzhen Carewell Electronics Co., a subsidiary of Lepu Medical, is a pioneer in applying artificial intelligence technology to ECG auto-diagnosis, distributing innovative AI medical devices to over 100 countries.

What the Web Says

Shenzhen Carewell Electronics is a small to medium-sized Chinese company specializing in AI-powered medical devices, particularly in cardiology and patient monitoring. They are known for their AI-ECG Platform and AI-ECG Tracker, which have received FDA and EU certifications. The company focuses on producing high-quality, innovative AI medical devices and sells them in over 100 countries. While direct customer and employee reviews are scarce on major platforms like G2, Glassdoor, Capterra, and Reddit, the company is recognized in healthcare IT discussions for its contributions to computational healthcare and AI applications in medicine.

Overall: Positive

Strengths

  • FDA and EU certified products, indicating adherence to international standards.
  • Pioneering in AI-ECG auto-diagnosis.
  • Products designed to improve detection efficiency of arrhythmias.
  • Devices can be used in various healthcare settings, including those lacking specialist doctors.
  • Focus on high-quality, innovative AI medical devices.
  • Global reach with sales in over 100 countries.

Limitations

  • Limited public reviews on major platforms like G2, Glassdoor, Capterra, and Reddit.
  • AI-ECG interpretation results are advisory only and not intended as the sole means of diagnosis.
  • Products are not for use in life-supporting systems or ECG monitoring and alarm devices.
  • Potential challenges with regulatory divergence between China's NMPA and international standards.
  • Supply chain concentration risk with China for medical device components.
  • Vulnerability to raw material cost volatility.

Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT reviewers, Reddit, Yicai Global, FDA, IndexBox, PMC, MDPI, FCC Report

Last updated: 2026-07-19

Videos

News, demos, and interviews about Shenzhen Carewell Electronics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Shenzhen Carewell Electronics →

View all on YouTube

Press & Coverage

carewellu51efu6c83u5c14
AI-ECG Platform Gets FDA Clearance
Shenzhen Carewell Electronics Co., Ltd., a subsidiary of Lepu Medical, announced on November 19, 2018, that its AI-ECG Platform, an artificial intelligence automatic analysis and diagnosis system for ECG, received FDA clearance. This marks it as the first Chinese innovative medical device in the AI ECG field to achieve FDA clearance.
2018-11
NAI 500
Lepu Medical Technology's AI-ECG Tracker Gains US FDA's Seal
Lepu Medical Technology Beijing's AI-ECG Tracker, developed by its Shenzhen Carewell Electronics unit, received registration approval from the US FDA on March 24, 2020, following its EU certification last year. The AI-ECG Tracker is intended for qualified healthcare professionals to assess arrhythmias using ECG data from adults.
2020-03
South China Morning Post
Chinese medical device maker's US$2 a day heart attack risk warning system faces resistance in US
Lepu Medical, through its subsidiary Shenzhen Carewell Electronics, developed an AI-powered heart attack risk warning system that gained FDA approval but faces resistance from US healthcare providers. The system, backed by a large patient dataset, offers data analytics at a low cost, potentially disrupting existing income models for doctors.
2019-10
Semantic Scholar
Artificial Intelligence in Translational Medicine
This peer-reviewed article from November 2021 mentions Shenzhen Carewell Electronics, Ltd. and its AI-ECG Platform (K180432) for assisting physicians in ECG interpretation and the AI-ECG Tracker (K200036) for improving the detection efficiency of non-persistent arrhythmias.
2021-11
BMJ Health & Care Informatics
How machine learning is embedded to support clinician decision making: an analysis of FDA-approved medical devices
A peer-reviewed article from April 2021 references Shenzhen Carewell Electronics, Ltd.'s AI-ECG Platform (K180432) as an FDA-approved medical device utilizing machine learning for clinician decision support. The article analyzes how ML devices assist with diagnostic and triage tasks.
2021-04
Frontiers in Cardiovascular Medicine
Artificial intelligence in cardiology: Hope for the future and power for the present
This peer-reviewed article from September 2022 lists Shenzhen Carewell Electronics Co., Ltd.'s AI-ECG Tracker (K200036) as an FDA-approved device for the assessment of arrhythmias using ECG data. It highlights the growing role of AI in cardiology.
2022-09
GLOBAL IP NEWS
Electrocardiogram Monitoring and Analyzing System Patent Application
On July 16, 2026, Shenzhen Carewell Electronics Co Ltd applied for a Chinese patent for an Electrocardiogram Monitoring and Analyzing System. The patent application number is CN202610257758 20260304.
2026-07
FDA
510(k) Premarket Notification K113485
The FDA issued a 510(k) Premarket Notification decision for Shenzhen Carewell Electronics Co., Ltd.'s Electrocardiograph (K113485) on April 25, 2012, determining it to be substantially equivalent to legally marketed predicate devices.
2012-04

Frequently Asked Questions

Shenzhen Carewell Electronics offers the AI-ECG Platform and AI-ECG Tracker, which utilize deep learning algorithms for automatic ECG analysis. These systems are designed to assist qualified healthcare professionals in assessing common cardiac abnormalities, including arrhythmias, myocardial infarction, and ventricular hypertrophy, with reported accuracy exceeding 95% for major cardiovascular diseases.
Carewell's AI-ECG Platform is reported to accurately diagnose arrhythmias, ventricular hypertrophy, and myocardial infarction with an overall accuracy of more than 95%. Their AI-ECG CHECKME product, specifically, boasts 98.3% accuracy driven by a deep learning neural network trained on over 47 million annotated data.
Yes, Shenzhen Carewell Electronics has obtained ISO 13485 and CE certificates, and their ECG products, including the AI-ECG Platform, have received FDA clearance in the United States. They also adhere to EU MDR regulations, demonstrating their commitment to international medical device software compliance.
In addition to their AI ECG solutions, Carewell manufactures ultrasound scanners as part of their medical imaging systems portfolio. They also offer multi-parameter patient monitors, such as the CPM-9000 series, which can measure various physiological parameters including ECG, NIBP, SpO2, RESP, TEMP, PR, and include arrhythmia and ST segment analysis.
While specific details on support tiers are not publicly detailed, Carewell provides general contact information for inquiries and their website lists a 'Support' section. Their AI-ECG Platform includes components like an AI-ECG Workstation for fast computing and a web-based Management Portal for task management and report review, implying a comprehensive system requiring ongoing technical assistance.
Founded in 2002, Shenzhen Carewell Electronics is a national Hi-Tech enterprise with a significant global presence, distributing products to over 100 countries. The company joined LEPU Medical in 2017, a leading Chinese group in cardiovascular interventions, which enhances its stability and technological backing in the advanced AI medical device market.
Carewell's AI-ECG Platform is designed to integrate with compatible resting ECG devices that can export recordings in various formats, including Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, or MFER ECG. The system provides a professional diagnostic client for physicians to review, modify, and confirm AI-generated interpretations, facilitating integration into clinical workflows.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.